The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis-Reference-Cited by-同舟云学术

The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis

Published:2020-12 Issue: Volume:208 Page:112858
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Arena Chiara,Gado Francesca,Di Cesare Mannelli Lorenzo^ORCID,Cervetto Chiara^ORCID,Carpi Sara^ORCID,Reynoso-Moreno Ines^ORCID,Polini Beatrice,Vallini Erika,Chicca Stefano,Lucarini Elena^ORCID,Bertini Simone,D’Andrea Felicia^ORCID,Digiacomo Maria^ORCID,Poli Giulio,Tuccinardi Tiziano^ORCID,Macchia Marco,Gertsch Jürg,Marcoli Manuela,Nieri Paola,Ghelardini Carla,Chicca Andrea^ORCID,Manera Clementina^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference90 articles.

1. Cannabinoid signaling and neuroinflammatory diseases: a melting pot for the regulation of brain immune responses;Chiurchiù;J. Neuroimmune Pharmacol.,2015

2. A Guide to targeting the endocannabinoid system in drug design;Stasiulewicz;Int. J. Mol. Sci.,2020

3. Endocannabinoid modulation of microglial phenotypes in neuropathology;Tanaka;Front. Neurol.,2020

4. Novel approaches and current challenges with targeting the endocannabinoid system;Morales;Expet Opin. Drug Discov.,2020

5. Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis;Navarrete;Neurobiol. Dis.,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity;European Journal of Pharmacology;2024-08

2. Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential;Current Medicinal Chemistry;2023-04

3. New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2;International Journal of Molecular Sciences;2023-01-21

4. New cannabinoid receptor type 1 and 2 agonists and applications to understanding the endocannabinoid system: A chemical approach;Neurobiology and Physiology of the Endocannabinoid System;2023

5. Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia;International Journal of Molecular Sciences;2022-10-02